ellagic acid protects the brain against 6-hydroxydopamine induced neuroinflammation in a rat model of parkinson’s disease

Authors

yaghoob farbood

alireza sarkaki

mojtaba dolatshahi

seyed mohammad taqhi mansouri

abstract

introduction: neuroinflammation may play as an important risk factor in progressive degeneration of dopaminergic cells. antioxidants have protective effects against free radicalsinduced neural damage in parkinson’s disease (pd). in the present study, we examined the effects of ellagic acid (ea) on locomotion and neuroinflammatory biomarkers in a rat model of pd induced by 6-hydroxidopamine (6-ohda). methods: 6-ohda (16 μg/2 μl) was injected into the right medial forebrain bundle (mfb) in mfb-lesioned rat’s brain. sham group received vehicle instead of 6-ohda. pd-model was confirmed by rotational test using apomorphine injection. ea (50 mg/kg/2 ml, by gavages) was administered in pd+ea group. one group of mfb-lesioned rats received pramipexole (ppx 2 mg/kg/2 ml, by gavages) as positive control group (pd+ppx group). motor activity was assessed by stride length and cylinder tests. the levels of tnf-α and il-1β were measured in both striatum and hippocampus tissues. results: mfb lesion caused significant reduction of stride-length (p<0.001) and also increased the contralateral rotations (p<0.001) and score of the cylinder test (p<0.001). use of 6-ohda to induce the pd significantly increased the levels of tnf-α (p<0.001) and il-1β (p<0.001) in mfb-lesioned rats. ea significantly restored all of the above parameters. discussion: ea can improve the motor impairments in the mfb-lesioned rats via reducing the neuroinflammatory biomarkers and protect the brain against free radicals-induced neural damage. the results suggest that ea can be helpful in management of pd treatment.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Ellagic Acid Protects the Brain Against 6-Hydroxydopamine Induced Neuroinflammation in a Rat Model of Parkinson’s Disease

Introduction: Neuroinflammation may play as an important risk factor in progressive degeneration of dopaminergic cells. Antioxidants have protective effects against free radicalsinduced neural damage in Parkinson’s disease (PD). In the present study, we examined the effects of ellagic acid (EA) on locomotion and neuroinflammatory biomarkers in a rat model of PD induced by 6-hydroxidopamin...

full text

Ellagic Acid Protects the Brain Against 6-Hydroxydopamine Induced Neuroinflammation in a Rat Model of Parkinson’s Disease

INTRODUCTION Neuroinflammation may play as an important risk factor in progressive degeneration of dopaminergic cells. Antioxidants have protective effects against free radicals-induced neural damage in Parkinson's disease (PD). In the present study, we examined the effects of ellagic acid (EA) on locomotion and neuroinflammatory biomarkers in a rat model of PD induced by 6-hydroxidopamine (6-O...

full text

Ellagic acid improves hyperalgesia and cognitive deficiency in 6-hydroxidopamine induced rat model of Parkinson’s disease

Objective(s):Parkinson's disease (PD) is known for motor impairments. But often, there are non-motor symptoms such as cognitive deficiency and pain misperception, owing to possible role of nigrostriatal pathway. Antioxidants have protective effect on free radical-induced neuronal damage in PD. To further address, we examined the effects of ellagic acid (EA) in a rat model of PD induced by 6-hyd...

full text

Diadenosine tetraphosphate protects against injuries induced by ischemia and 6-hydroxydopamine in rat brain.

Diadenosine tetraphosphate (AP4A), an endogenous diadenosine polyphosphate, reduces ischemic injury in the heart. In this study, we report the potent and protective effects of AP4A in rodent models of stroke and Parkinson's disease. AP4A, given intracerebroventricularly before middle cerebral artery (MCA) ligation, reduced cerebral infarction size and enhanced locomotor activity in adult rats. ...

full text

Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease.

Loss-of-function mutations in the PARK2 gene are the major cause of early onset familial Parkinson's disease. The gene product, parkin, is an E3 ligase of the ubiquitin-proteasome pathway involved in protein degradation. Dopaminergic neuron loss may result from the toxic accumulation of parkin substrates, suggesting a key role for parkin in dopaminergic neuron survival. In this study, we have i...

full text

ellagic acid improves hyperalgesia and cognitive deficiency in 6-hydroxidopamine induced rat model of parkinson’s disease

objective(s):parkinson&apos;s disease (pd) is known for motor impairments. but often, there are non-motor symptoms such as cognitive deficiency and pain misperception, owing to possible role of nigrostriatal pathway. antioxidants have protective effect on free radical-induced neuronal damage in pd. to further address, we examined the effects of ellagic acid (ea) in a rat model of pd induced by ...

full text

My Resources

Save resource for easier access later


Journal title:
basic and clinical neuroscience

جلد ۶، شماره ۲، صفحات ۸۳-۹۰

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023